LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2026)

LifeStance Health (LFST) has 7 years of Net Income towards Common Stockholders data on file, last reported at $14.2 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $14.2 million, up 1908.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.2 million (up 165.09% YoY), and the FY2025 annual result was $9.7 million, up 116.82% from the prior year.
• Net Income towards Common Stockholders advanced to $14.2 million in Q1 2026 per LFST's latest filing, from $11.7 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $14.2 million in Q1 2026 and troughed at -$68.7 million in Q2 2022.
• A 5-year average of -$25.6 million and a median of -$23.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2023 and 2026: Net Income towards Common Stockholders tumbled 62.69% in 2023, then soared 1908.89% in 2026.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$46.7 million in 2022, then increased by 3.64% to -$45.0 million in 2023, then soared by 84.18% to -$7.1 million in 2024, then surged by 264.06% to $11.7 million in 2025, then gained by 22.07% to $14.2 million in 2026.
• Business Quant data shows LFST's Net Income towards Common Stockholders at $14.2 million in Q1 2026, $11.7 million in Q4 2025, and $1.1 million in Q3 2025.